NASDAQ
1.59USD
+0.11 (+7.43%)
We have scored 12 news catalysts on Geron Corporation (GERN) over the past 12 months. The biggest single-day move next to one of them came Feb 18, 2026, when GERN closed +7.8%: “Top 3 Health Care Stocks That May Collapse This Quarter”. Coverage across the window leans negative (average ticker sentiment −0.13). Most of the impact sits in price momentum and sector healthcare.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Latest scored catalyst for GERN: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Market cap
1B
P/E
—
EPS
—
Beta
0.59
52W range
1.04-2.01
Day range
1.49–1.62
Open
1.49
Prev close
1.48
Volume
12.5M
Avg volume
12.1M
Dividend
0.00
IPO
1996-07-31
Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid blood cancers. Its primary drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical evaluation. This therapy aims to suppress the unchecked proliferation of cancerous stem and progenitor cells characteristic of myeloid hematologic malignancies. Imetelstat is being developed to address low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Established in 1990, Geron's corporate headquarters are located in Foster City, California.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Geron Corporation — not a sector bucket. Click an edge to see the articles that established the link.
